A SIMPLE KEY FOR ABBV-744 BRD4 INHIBITION IN CANCER CELL LINES UNVEILED

These side effects had been notably milder when compared to an inhibitor of each bromodomains. A detailed molecular Investigation also exposed that ABBV-744 preferentially inhibits the expression of Androgen Receptor (AR)-dependent genes.  ― Stephen Taylor88 These preclinical studies give paradigms for upcoming clinical trials in AML, and using